Mumbai, March 27 -- Pharma companies Sanofi India and Cipla Limited on Tuesday announced an exclusive partnership for the distribution and promotion of Sanofi Indias Central Nervous System (CNS) product range in India.

As a part of this partnership, Cipla will be responsible for the distribution of Sanofi Indias six CNS brands including Frisium, a leading brand in the anti-epileptic medication category, according to a press release.

While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla will leverage its capabilities and robust India-wide network of strong marketing and sales professionals, distributors, institutions, and market outreach progr...